All Stories

Keros considers a sale, strengthens defense against potential activist investors

Keros Therapeutics is considering whether it needs to find a buyer, while strengthening its stockholder rights as activist investors circle.

Apr 10, 2025 - 13:52
 0
Keros considers a sale, strengthens defense against potential activist investors
Keros Therapeutics is considering whether it needs to find a buyer, while strengthening its stockholder rights as activist investors circle.
Read More

Tags:

Previous Article

Jazz Pharma forks over $145M to shake off antitrust claims tied to narcolepsy dr...

Next Article

Disability advocates rally against Medicaid cuts

Related Posts

Fierce Biotech Layoff Tracker 2025: BMS cuts 57 CA jobs; Atea reduces headcount by 25%

Fierce Biotech Layoff Tracker 2025: BMS cuts 57 CA jobs...

Mar 7, 2025  0

Pliant pauses phase 2 lung fibrosis trial on advice of safety committee

Pliant pauses phase 2 lung fibrosis trial on advice of ...

Feb 10, 2025  0

After Eric Green's exit, new leader of NIH's genome research institute put on administrative leave: Stat

After Eric Green's exit, new leader of NIH's genome res...

Apr 1, 2025  0